- JoNova - https://www.joannenova.com.au -

The battle worth fighting for: Let us and our doctors choose what medicine we take

Adriana Midori Takara,

Adriana Midori Takara,

Adriana Midori Takara was only 38 when she died of Covid in Australia last week. She instantly became a posterchild for the vaccine advertising campaign. But the true story may be something else entirely. Rebecca Weisser treads where few dare:  Adriana’s family tried to get her ivermectin, which may have have saved her, but even though they found a doctor willing to try, he was not allowed to.

The Guardian and MSN both report relatives saying she wanted but had been unable to get any vaccine.  But Rebecca Weisser reports that other journalists heard she was vaccinated, and asked whether she had a vaccine dose. The NSW authorities, who would surely be very interested in her vaccine status, won’t answer that question.

Meanwhile no one is turning the latest 44 and 48 year old victims of Astra-Zenica side-effects into posterchilds for anything. Where are their photos?

This is the battle worth fighting for.

The fastest way to stop lockdowns is by allowing every doctor and patient the choice to use cheap antivirals, not just limit their choices to drugs that earn their manufacturers $45billion dollars.  Ivermectin can be used prophylactically to prevent as many as 86% of infections. Vitamin D could also reduce the spread, the hospitalization and help get the state out of restrictions. At the very least, Vitamin D reduced intensive care by 80%. If cheap safe drugs reduced Covid infections by 10% they’d be worth it. The risks are so low.

Premier Gladys Berejiklian must be getting desperate (the people of NSW are). If ever there was a time, surely it’s now…

Chronicle of a Covid death foretold

Rebecca Weisser, The Spectator

Friends in the Brazilian community said that she had received her first jab just before she tested positive. Yet when a journalist told NSW chief health officer Kerry Chant that ‘Some people close to her are suggesting she had at least one dose of the vaccine,’ Chant replied that she’d have to check but she’d been advised that Adriana did not have any underlying health issues. It was an odd comment because Chant should be briefed on the vaccine status of every Covid victim since it is the first question that every journalist wants answered. Yet days later Chant has yet to confirm or deny Adriana’s vaccine status. It floats in the air like a spectral phantom.

Yet the shocking truth is that Adriana died not because she was unable to get a Pfizer vaccine if that is indeed what happened – Sydney is awash with AstraZeneca – she died because she was unable to access the life-saving early treatment that her family desperately sought to provide.

McCullough contacted the Covid Medical Network who are set up to provide this therapy to every person in Australia who tests positive. One of the doctors was appointed by the family but by then it was too late. Adriana had been hospitalised and could not have been saved even if her doctor had been allowed to treat, which he was not, disregarding the wishes of her next-of-kin. Yet her doctor is adamant that had she received treatment at diagnosis, she would be alive today.

At the same time vaccine injuries and deaths in the under-50s are mounting. According to official UK government data, there have already been 180 people under 50 who developed thrombosis with thrombocytopenia (TTS) after the AstraZeneca shot and 29 who died as well as 463 reports of myocarditis and pericarditis, mostly in the young. Yet this is only a handful of the more than a million adverse reports including nearly 1,500 deaths.

Doctors are legally allowed to prescribe ivermectin “off label” in Australia — Greg Hunt the Health Minister said so, but they need information and well informed, but determined patients.

Start with this one — the Big peer reviewed study: The Ivermectin Review: showing how it may prevent 86% of Covid cases. 

More background information below:

The wonder drug that disappeared

My summary of Ivermectin

If you only email friends one link — make it this story. It’s the biggest medical scandal since 1850— Why is a cheap safe drug being ignored? Could it be that there would be no medical emergency and no need to rush out other riskier new treatments which are still classed as “experimental” if there was a safe alternative? There are billions of reasons to ask this question but newspapers wouldn’t publish the story. In desperation, some Americans are going to court to get rulings to order doctors to use Ivermectin on their loved ones. Even if they win, sometimes hospitals still refuse to use it on patients with few options left. One family hired a helicopter to take their mother away from intensive care in a hospital that refused to give Ivermectin (and had a happy ending). The debate is so suppressed, there are rumours the US President was treated with it in secret last year.

Ivermectin has also been used, with apparent success in India, Peru and Mexico (and so many other places). Covid cases fell in the states of India that approved Ivermectin use but rose in Tamil Nadu where it wasn’t permitted. Despite the success,  India’s Health dept suddenly stopped Ivermectin use again and people in India  are suing the WHO in disgust. In Peru, Ivermectin cut covid deaths by 75% in 6 weeks.

The FDA and others will say there is little evidence of success so far, but that’s a scandal in itself. Why are there no large trials? And why are other drugs like Remdesivir approved with only one trial?  Ivermectin is so safe some 3.7 billion doses have already been used around the world. The inventors won a Nobel Prize for its discovery in 2015. We’ve known it might be useful since April last year, when an Australian group searched through many cheap safe drugs looking for any that might help against Covid. The news then was “Another possible cure for coronavirus, found in sheep dip: Ivermectin”. This was just a lab study, and it suggested doses would need to be too high. Even so, successes keep turning up in the real world? By July last year there were already signs Ivermectin could save as many as 50%Why were large trials not started then? The UK trial is hobbled from the start.

9.8 out of 10 based on 76 ratings